Providence Medical Technology, Inc. (PMT) announced that two-year follow-up data for DTRAX Facet System patients would be available in an electronic poster session at the Congress of Neurological Surgeons Annual Meeting in San Francisco, October 19–23.
Providence Medical Technology, Inc. today announced that the U.S. Patent and Trademark Office issued patents 8,834,530, Cervical Distraction Method; 8,834,472, Vertebral Joint Implants and Delivery Tools, and 8,828,062, Vertebral Joint Implants and Delivery Tools to the company in September 2014.
Providence Medical Technology, Inc. (PMT) today announced that five U.S. patents have been issued in the past 12 months protecting the DTRAX family of technologies, bringing the total number of U.S. patents issued to the company by the U.S. Patent Office to seven.
Providence Medical Technology, Inc. today announced that it has closed a $6.8 million Series C round of financing. Stanmore Medical Investments led the round through its MedVest Fund One, and was joined by Aphelion Capital and RCT Ventures.
